NCT07217015Phase 2Active not recruiting

A Study of KT-621 Administered Orally to Participants With Moderate to Severe Atopic Dermatitis

Study sponsor: Kymera Therapeutics, Inc. · KYMR

Compare the available registry edits below. Primary completion is the date data collection ends for the main study measures; it does not tell you when results will be published.

Open ClinicalTrials.gov record CSV export · Pro

Primary completion2027-06Estimated

Enrollment · participants200Estimated

Source updated2026-06-30Last update listed in the registry record

Version history

Changes to this trial

Last 12 months

Pro unlocks the full available history and CSV export. View Pro features

Posted 2026-06-30 · 1 field changed

Recruitment status changed

− Before

~~Recruiting~~

+ After

Active not recruiting

Check registry source